Following the approval of delamanid and pretomanid as new drugs to treat drug-resistant tuberculosis, there is now a renewed interest in bicyclic nitroimidazole scaffolds as a source of therapeutics against infectious diseases. We recently described a nitroimidazopyrazinone bicyclic subclass with promising antitubercular and antiparasitic activity, prompting additional efforts to generate analogs with improved solubility and enhanced potency. The key pendant aryl substituent was modified by (i) introducing polar functionality to the methylene linker, (ii) replacing the terminal phenyl group with less lipophilic heterocycles, or (iii) generating extended biaryl side chains. Improved antitubercular and antitrypanosomal activity was observed with the biaryl side chains, with most analogs achieved 2- to 175-fold higher activity than the monoaryl parent compounds, with encouraging improvements in solubility when pyridyl groups were incorporated. This study has contributed to understanding the existing structure-activity relationship (SAR) of the nitroimidazopyrazinone scaffold against a panel of disease-causing organisms to support future lead optimization.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770830 | PMC |
| http://dx.doi.org/10.1021/acs.jmedchem.0c01372 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evans syndrome as a presentation in systemic lupus erythematous, coexisting with Hashimoto's thyroiditis and pernicious anemia: a case report.
J Med Case Rep
December 2024
Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Background: Evans syndrome is a rare disorder characterized by the simultaneous or sequential combination of autoimmune hemolytic anemia and immunological thrombocytopenia, together with a positive direct antiglobulin test. This syndrome, which can be primary or secondary, is a rare initial manifestation of autoimmune diseases, notably systemic lupus erythematosus, with 1.7-2.
View Article and Find Full Text PDFTwo rare cases of Brucella-induced endocarditis and myopericarditis: challenges in diagnosis.
J Infect Dev Ctries
November 2024
Clinic for Cardiology, University Clinical Center of Serbia, Koste Todorovića 8, 11000, Belgrade, Serbia.
Introduction: Brucellosis is one of the most common zoonotic infections in the world. Cardiac complications of the disease are usually in the form of endocarditis, and, to a lesser extent, in the form of myopericarditis.
Case: We report the case of a 34-year-old female admitted with signs of fever, nausea, and headache.
Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA.
Lupus Sci Med
December 2024
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA
Objective: To characterise the changing trends in the pharmacological management of SLE in the USA between 2007 and 2023 as new treatment options emerged.
Methods: In a retrospective cohort study using data from OptumLabs Data Warehouse, we characterised the annual prevalent (ie, all) and incident (ie, new) use of antimalarials, glucocorticoids and immunosuppressive medications among patients with SLE from 2007 to 2023 and assessed for changing trends over time.
Results: We identified 19 122 adults with SLE; they were 51.
Unravelling the challenge of cotrimoxazole and rifampin resistance in B. melitensis and B. abortus: A systematic review and meta-analysis.
PLoS Negl Trop Dis
December 2024
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Brucellosis, caused by B. abortus and B. melitensis, is a significant health threat, and standard treatments like rifampin and cotrimoxazole are facing rising antibiotic resistance.
- A systematic review analyzed 59 studies from 21 countries, revealing that cotrimoxazole resistance is at 3.4% and rifampin resistance at 4.6%, with trends showing increases over time, especially in B. melitensis.
- The study underscores the need for ongoing monitoring of antibiotic resistance, highlighting variations based on time, geography, and species, to inform treatment guidelines for pediatric brucellosis.
CNS histoplasmosis coexisting with pulmonary tuberculosis in a HIV negative patient: case report.
BMC Infect Dis
November 2024
Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, India.
Article Synopsis
- Tuberculosis is common in India, while Histoplasmosis is less reported; co-infection is rare but challenging to diagnose due to symptom overlap.
- A 62-year-old man was diagnosed with both conditions, initially treated with appropriate medications, but experienced complications due to drug interactions.
- Follow-up treatment adjustments led to significant improvement, highlighting the need for careful monitoring and awareness of potential drug interactions in similar cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!